Kazia Therapeutics Ltd (KZIA) stock
KZIANasdaqPharmaceutical PreparationsFiscal year ends June 30
$5.49+0.18 (+3.39%)
Close on Nov 18, 2026Market cap $8.89MP/E –Yield –
Kazia Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Kazia Therapeutics's total debt was A$98.81K at Dec 31, 2025. For fiscal 2025 it was A$395.64K, down 37.6% from the year before. The highest annual figure on record is A$1.84M in fiscal 2022.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | A$395.64K | -37.6% |
| FY2024 | Jun 30, 2024 | A$634.00K | -64.7% |
| FY2023 | Jun 30, 2023 | A$1.80M | -2.4% |
| FY2022 | Jun 30, 2022 | A$1.84M | – |
| FY2021 | Jun 30, 2021 | A$0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | A$98.81K | -72.5% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | A$395.64K | -78.0% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | A$140.74K | -74.5% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | A$634.00K | -65.6% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | A$359.30K | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | A$1.80M | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | A$552.32K | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | A$1.84M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | A$0 | – |
See a number that looks wrong?